Identifying reliable predictors of axillary pCR is essential for safely omitting ALND in selected patients.<h4>Materials and methods</h4>This retrospective cohort study included 60 women with HER2+ breast cancer and axillary involvement treated with NAC followed by surgery between 2015 and 2022. The gene discussed is ERBB2; the disease is breast carcinoma.